#158FUZKK selection 101–300
Basilea Pharmaceutica
Switzerland · Switzerland
BiologicsFinished dosage forms and small molecules
Manufacturing profile
- Country
- Switzerland
- Regulatory region
- Switzerland
- ISO
- CHE
Selection basis
The company is placed in positions 101–300 as a manufacturer, biotechnology company, generics player or CDMO with practical relevance to the FUZKK utility catalog.
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.
Representative manufacturing and QC chain
- 1Cell bank or microbial seed
- 2Upstream culture or fermentation
- 3Clarification and chromatography
- 4UF/DF, formulation and sterile filtration
- 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC
- 6Raw-material receipt and identification
- 7Dispensing, blending and granulation
- 8Tableting, encapsulation or solution preparation
- 9Packaging and labelling
Relevant FUZKK packages
Product/API utilities
Lumex — instrumental QC
LabEx — laboratory QC
Biologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality CheckerAssay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality Checker
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. The mapping does not claim actual use of FUZKK, a specific installed equipment model or a product not confirmed by the public company profile.
Methodology